SMT201500175B - Derivati di azaindoli come inibitori delle proteine chinasi abl e src - Google Patents

Derivati di azaindoli come inibitori delle proteine chinasi abl e src

Info

Publication number
SMT201500175B
SMT201500175B SM201500175T SM201500175T SMT201500175B SM T201500175 B SMT201500175 B SM T201500175B SM 201500175 T SM201500175 T SM 201500175T SM 201500175 T SM201500175 T SM 201500175T SM T201500175 B SMT201500175 B SM T201500175B
Authority
SM
San Marino
Prior art keywords
inhibitors
azaindole derivatives
src proteins
kinase abl
abl
Prior art date
Application number
SM201500175T
Other languages
English (en)
Italian (it)
Inventor
Abdelaziz Yasri
Gwenael Cheve
Cedric Bories
Louis Delon
Original Assignee
Oribase Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oribase Pharma filed Critical Oribase Pharma
Publication of SMT201500175B publication Critical patent/SMT201500175B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SM201500175T 2009-02-12 2015-07-22 Derivati di azaindoli come inibitori delle proteine chinasi abl e src SMT201500175B (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20227909P 2009-02-12 2009-02-12
FR0900631A FR2941948B1 (fr) 2009-02-12 2009-02-12 Derives d'azaindoles en tant qu'inhibiteur des proteines kinases abl et src
PCT/IB2010/000593 WO2010092489A1 (en) 2009-02-12 2010-02-12 Derivatives of azaindoles as inhibitors of protein kinases abl and src

Publications (1)

Publication Number Publication Date
SMT201500175B true SMT201500175B (it) 2015-09-07

Family

ID=40886859

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201500175T SMT201500175B (it) 2009-02-12 2015-07-22 Derivati di azaindoli come inibitori delle proteine chinasi abl e src

Country Status (15)

Country Link
US (1) US8580815B2 (https=)
EP (1) EP2396325B1 (https=)
JP (1) JP5583698B2 (https=)
AU (1) AU2010212560B2 (https=)
CA (1) CA2751478A1 (https=)
DK (1) DK2396325T3 (https=)
ES (1) ES2540962T3 (https=)
FR (1) FR2941948B1 (https=)
HR (1) HRP20150697T8 (https=)
HU (1) HUE024989T2 (https=)
PL (1) PL2396325T3 (https=)
PT (1) PT2396325E (https=)
SI (1) SI2396325T1 (https=)
SM (1) SMT201500175B (https=)
WO (1) WO2010092489A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX365640B (es) 2012-12-21 2019-06-10 Plexxikon Inc Compuestos y metodos para la modulacion de quinasas y sus indicaciones.
FR3000493A1 (fr) * 2012-12-28 2014-07-04 Oribase Pharma Nouveaux inhibiteurs de proteines kinases
FR3000494B1 (fr) * 2012-12-28 2015-08-21 Oribase Pharma Nouveaux derives d'azaindoles en tant qu'inhibiteurs de proteines kinases
FR3000492B1 (fr) * 2012-12-28 2015-09-11 Oribase Pharma Nouveaux derives azaindole en tant qu'inhibiteurs multikinases
WO2017156350A1 (en) 2016-03-09 2017-09-14 K-Gen, Inc. Methods of cancer treatment
MA49014A (fr) * 2017-03-21 2020-02-05 Arbutus Biopharma Corp Dihydroindène-4-carboxamides substitués, leurs analogues et procédés d'utilisation correspondant
WO2021222442A1 (en) 2020-04-29 2021-11-04 Plexxikon Inc. Synthesis of heterocyclic compounds
CN111943947B (zh) * 2020-07-24 2021-04-30 重庆文理学院 1H-吡咯[2,3-b]吡啶衍生物及其合成方法与应用
KR20230104781A (ko) 2020-10-05 2023-07-10 인라이븐 테라퓨틱스, 인크. Bcr-abl 티로신 키나아제의 억제를 위한 5- 및 6-아자인돌 화합물
MX2023003996A (es) * 2020-10-05 2023-06-15 Enliven Inc Compuestos de 7-azaindol para la inhibicion de tirosina cinasas bcr-abl.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0330042D0 (en) * 2003-12-24 2004-01-28 Pharmacia Italia Spa Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions them
GB0330043D0 (en) * 2003-12-24 2004-01-28 Pharmacia Italia Spa Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them
JP2008503473A (ja) * 2004-06-17 2008-02-07 プレキシコン,インコーポレーテッド C−kit活性を調節する化合物
US7709645B2 (en) 2004-07-27 2010-05-04 Sgx Pharmaceuticals, Inc. Pyrrolo-pyridine kinase modulators
WO2006015123A1 (en) 2004-07-27 2006-02-09 Sgx Pharmaceuticals, Inc. Pyrrolo-pyridine kinase modulators
US7361764B2 (en) 2004-07-27 2008-04-22 Sgx Pharmaceuticals, Inc. Pyrrolo-pyridine kinase modulators
WO2006104971A1 (en) * 2005-03-28 2006-10-05 Bristol-Myers Squibb Company Atp competitive kinase inhibitors
KR101104666B1 (ko) * 2006-09-06 2012-01-13 에프. 호프만-라 로슈 아게 단백질 키나제 억제제로서의 헤테로아릴 유도체
US8148361B2 (en) * 2006-11-10 2012-04-03 Bristol-Myers Squibb Company Kinase inhibitors
WO2008144253A1 (en) * 2007-05-14 2008-11-27 Irm Llc Protein kinase inhibitors and methods for using thereof
KR20100122505A (ko) * 2008-02-29 2010-11-22 어레이 바이오파마 인크. Raf 저해물질 화합물 및 이들의 이용 방법
ES2647317T3 (es) * 2008-11-03 2017-12-20 Syntarga B.V. Análogos de CC-1065 y sus conjugados

Also Published As

Publication number Publication date
HUE024989T2 (en) 2016-01-28
HRP20150697T1 (hr) 2015-08-14
ES2540962T3 (es) 2015-07-15
AU2010212560B2 (en) 2016-01-21
HRP20150697T8 (xx) 2015-11-06
SI2396325T1 (sl) 2015-08-31
US20110312959A1 (en) 2011-12-22
PT2396325E (pt) 2015-08-21
PL2396325T3 (pl) 2015-10-30
DK2396325T3 (en) 2015-06-29
EP2396325B1 (en) 2015-04-01
WO2010092489A1 (en) 2010-08-19
JP2012517465A (ja) 2012-08-02
FR2941948B1 (fr) 2013-04-05
FR2941948A1 (fr) 2010-08-13
AU2010212560A1 (en) 2011-08-11
EP2396325A1 (en) 2011-12-21
JP5583698B2 (ja) 2014-09-03
CA2751478A1 (en) 2010-08-19
US8580815B2 (en) 2013-11-12

Similar Documents

Publication Publication Date Title
SMT201500175B (it) Derivati di azaindoli come inibitori delle proteine chinasi abl e src
CY2023023I1 (el) Παραγωγα λακταμης χρησιμα ως αναστολεις μεταλλαγμενης idh1
SMT201600220B (it) Derivati di eterociclile biciclici come inibitori di fgfr chinasi per uso terapeutico
SMT201500195B (it) Derivati di chinolina e chinossalina quali inibitori delle chinasi
HUS1900012I1 (hu) Vegyületek és készítmények protein-kináz inhibitorokként
SMT201500191B (it) Derivati di benzopirazina sostituiti come inibitori delle chinasi fgfr per il trattamento di malattie tumorali
HRP20150318T1 (xx) Derivati kinazolin-4(3h)-ona koji se upotrebljavaju kao inhibitori pi3 kinaze
PL2504336T3 (pl) Nowe pochodne naftyrydynowe i ich zastosowanie jako inhibitorów kinaz
SMT201400086B (it) Derivati chinazolin-4(3H)-one usati come inibitoridi PI3 chinasi
SMT201300114T1 (it) Derivati di piridazina come inibitori di smo
SMT201500200B (it) Derivati di imidazo[1,2-a]piridina come inibitori delle chinasi fgfr per l'uso in terapia
SMP200800048B (it) Derivati pirimidinici utilizzati come inibitori dip13-chinasi
SMT201600338B (it) Formulazioni farmaceutiche comprendenti derivati di1-(beta-d- glucopiranosil)- 2-tienilmetilbenzene come inibitori di sglt
SMT201600005B (it) Derivati di picolinammide quali inibitori di chinasi
HUE036068T2 (hu) ATR kináz gátlószereiként alkalmazható pirazinszármazékok
SMT201400114B (it) Derivati di 2-arilimidazolo come inibitori dell'enzima pde10a
SMT201600108B (it) Derivato di pirazochinolina come inibitori di pde9
SMT201400155B (it) Composizioni farmaceutiche comprendenti derivati di 2-osso-1-pirrolidina
BRPI1012333A2 (pt) atropisômeros de derivados de 2-purinil-3-tolil-quinazolinonas e métodos de uso
EP2694517A4 (en) PROTEIN KINASE INHIBITORS
PL2413912T3 (pl) Preparaty farmaceutyczne zawierające pochodne nitrokatecholu oraz metody ich wytwarzania
ME02911B (me) Derivati c17 heteroarila oleanolinske kisjeline i postupci za njihovu upotrebu
SMT201400009B (it) Derivati eteroaromatici di ariltriazolo come inibitori dell'enzima pde 10A
SMT201500208B (it) Derivati di piridinone come inibitori della transglutaminasi tissutale
SMT201600076B (it) Derivati di 2-osso-1-pirrolidinil imidazotiadiazolo